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In Brief
Ranjbar et al. find that IFITM family
members 1–3, which restrict infection by
a wide range of viruses, inhibit a bacterial
pathogen, Mycobacterium tuberculosis
(MTb). MTb infection, signaling via TLR2
and TLR4, andMTb-induced cytokines all
induce IFITM1–IFITM3 gene
transcription. IFITM3, which has the
greatest anti-MTb activity, associates
with and increases acidification of MTb
phagosomes.
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The interferon (IFN)-induced transmembrane (IFITM)
proteins are critical mediators of the host antiviral
response. Here, we expand the role of IFITM pro-
teins to host defense against intracellular bacterial
infection by demonstrating that they restrict Myco-
bacterium tuberculosis (MTb) intracellular growth.
Simultaneous knockdown of IFITM1, IFITM2, and
IFITM3 by RNAi significantly enhances MTb growth
in human monocytic and alveolar/epithelial cells,
whereas individual overexpression of each IFITM
impairs MTb growth in these cell types. Further-
more, MTb infection, Toll-like receptor 2 and 4 li-
gands, and several proinflammatory cytokines
induce IFITM1–3 gene expression in human myeloid
cells. We find that IFITM3 co-localizes with early
and, in particular, late MTb phagosomes, and
overexpression of IFITM3 enhances endosomal
acidification in MTb-infected monocytic cells.
These findings provide evidence that the antiviral
IFITMs participate in the restriction of mycobacte-
rial growth, and they implicate IFITM-mediated
endosomal maturation in its antimycobacterial
activity.INTRODUCTION
Successful intracellular pathogens often use strategies to gain
access to cellular compartments required for their survival
ahead of the initiation of innate host antimicrobial mechanisms.
The well-characterized interferon (IFN)-induced transmembrane
(IFITM) gene family encodes highly conserved proteins that act
at early steps post-viral entry, thereby precluding establishment
of productive infection (Diamond and Farzan, 2013). In humans,
three IFITMs (IFITM1, IFITM2, and IFITM3) are widely ex-
pressed, and the genes encoding these restriction factors are
activated by types I and II IFN stimulation via IFN-sensitive
response elements (ISREs) in their regulatory regions (Ackrill
et al., 1991; Friedman et al., 1984; Kelly et al., 1985; Lewin
et al., 1991; Reid et al., 1989). While IFITM1–3 share substantial
sequence similarity, IFITM1 primarily is found at the cell periph-874 Cell Reports 13, 874–883, November 3, 2015 ª2015 The Authorsery due to its lack of an N-terminal 21 amino acid sequence that
promotes IFITM2 and IFITM3 recruitment to late endosomal/
lysosomal membranes (Jia et al., 2012; John et al., 2013;
Weston et al., 2014).
Virus restriction by individual IFITMs depends both on cell type
and the intracellular location of each family member. For
example, HIV, which undergoes viral envelope-cell membrane
fusion at the cell surface or within early endosomes, is more
restricted by IFITM1 (Lu et al., 2011), while influenza A virus,
which requires pH-dependent changes in envelope glycoprotein
conformation for viral fusion at late endosomes/lysosomes, is
more restricted by IFITM2/3 (Brass et al., 2009; Desai et al.,
2014; Feeley et al., 2011; John et al., 2013). IFITMs appear to
block viral infection by reducing host membrane fluidity at sites
of viral fusion through self-interactions and/or interactions with
nearby transmembrane proteins, leading to inhibition of viral
fusion pore formation and increased trafficking of trapped vi-
ruses to the lysosome for degradation (Desai et al., 2014; Lin
et al., 2013).
Evasion of lysosomal targeting is a survival strategy not only
for viruses, but also is employed by many intracellular bacte-
ria, including Mycobacterium tuberculosis (MTb). Virulent
MTb employs several mechanisms to prevent acidification
of the phagosome, thereby supporting its own survival (Stan-
ley and Cox, 2013). For example, the vacuolar ATPase
(v-ATPase), which is a primary mediator of endosomal acidifi-
cation, is excluded from the MTb-containing phagosome by
MTb’s bacterial tyrosine phosphatase (Bach et al., 2008; Stur-
gill-Koszycki et al., 1994; Wong et al., 2011). Intriguingly,
IFITM3 was found to co-immunoprecipitate with a subunit of
the v-ATPase (Wee et al., 2012). Furthermore, overexpression
of IFITM3 has been shown to increase endosomal pH and
expand the size and number of intracellular acidic compart-
ments (Feeley et al., 2011; Mudhasani et al., 2013; Wee
et al., 2012).
Here, we show that IFITM1, IFITM2, and IFITM3 are transcrip-
tionally activated in response to MTb infection and by several
proinflammatory cytokines produced during MTb infection.
Strikingly, depletion of these IFITMs significantly enhances
MTb growth in human monocytes. Furthermore, IFITM3 co-
localizes with the maturing MTb phagosome and its overexpres-
sion significantly restricts MTb growth and enhances endosomal
acidification in MTb-infected cells. These findings provide evi-
dence that IFITM family members directly inhibit a bacterial
pathogen.
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RESULTS
MTb Infection and TLR2/4-, MyD88-, and Cytokine-
Signaling Pathways Promote Expression of IFITM1, 2,
and 3 mRNA
To determinewhetherMTb infection induces transcriptional acti-
vation of the IFITMs, we infected primary human monocyte-
derived macrophages (MDMs) with the clinical MTb strains
CDC1551 and HN878 and measured IFITM1–3 mRNA levels at
3, 24, and 48 hr post-infection. All three genes were significantly
induced by CDC1551 and HN878 (Figure 1A) in MDMs, and a
similar response was seen at 6, 24, and 48 hr in H37Rv-MTb-
infected THP-1 monocytes (Figure 1B).
MTb triggers signaling by the pattern recognition receptors
(PRRs) Toll-like receptor (TLR)2 and TLR4, leading to the activa-
tion of innate immune response genes (Means et al., 1999;
Underhill et al., 1999; reviewed in Falvo et al., 2011). As shown
in Figure 1C, activation of THP-1 cells with the TLR2 agonist
Pam3Cys or with the TLR4 agonist lipopolysaccharide (LPS)
significantly induced IFITM1–3 gene expression, which reached
levels comparable to what was seen with live MTb infection by
48 hr post-stimulation.
Upon engagement of TLR2 or TLR4, the adaptor molecule
MyD88 transmits signals to downstream kinases, including
IRAK1 and TRAF6, which mediate activation of the MAPK and
NF-kB pathways and innate immune gene synthesis (Deguine
and Barton, 2014; Falvo et al., 2011). As shown in Figure 1D,
when MyD88 expression was depleted in THP-1 cells by small
hairpin RNA (shRNA), MTb-induced IFITM1–3 mRNA synthesis
was impaired significantly, indicating that this signaling adaptor
participates in IFITM gene induction byMTb.We obtained similar
results in THP-1 cells in which IRAK1 or TRAF6 expression was
ablated (Figure S1), indicating that TLR-mediated MyD88
signaling directly leads to IFITM transcription.
Although MTb induces the expression of type I IFN (Berry
et al., 2013), the prototypical stimulus of IFITM gene expression,
MTb also induces the expression of other proinflammatory cyto-
kines that are critical mediators of the host innate immune
response, including IL-1b, IL-6, and TNF (Etna et al., 2014).
Direct activation of the MTb-responsive PRRs TLR2 and TLR4
on THP-1 cells led to significantly enhanced levels of IL-1b,
TNF, and IL-6 mRNA by 24 hr (Figure S2). While IL-1b signaling
requires the MyD88/IRAK1/TRAF6 axis, TNF and IL-6 activate
distinct signaling pathways (Falvo et al., 2011). To investigate if
these cytokines directly induce IFITM gene expression in mono-
cytic cells, we treated THP-1 cells with recombinant IL-1b, IL-6,
or TNF, or, as a positive control, recombinant IFN-b, and as-Figure 1. IFITM1, IFITM2, and IFITM3Gene Expression Is Induced in Hum
via TLR2/4- and MyD88-Dependent Signaling Pathways
(A) MDMswere left uninfected (mock) or infected with MTb strains CDC1551 or HN
(B) THP-1 cells were left uninfected (mock) or infected with MTb strain H37Rv fo
(C) THP-1 cells were left untreated (mock) or treated with the TLR2 agonist Pam3
IFITM1–3 transcripts were measured.
(D) THP-1 cells in which MyD88 is constitutively ablated by shRNA, or THP-1 c
uninfected (mock) for 48 hr and IFITM1–3 transcripts were measured.
(E) THP-1 cells were left untreated (mock) or treated with recombinant IL-1b (100
IFITM1–3 and cyclophilin B mRNA levels were assayed using qPCR. Results are
***p < 0.005).
876 Cell Reports 13, 874–883, November 3, 2015 ª2015 The Authorssessed IFITM1–3 transcript levels. As anticipated, IFN-b stimula-
tion dramatically induced IFITM1–3 transcription (Figure 1E). By
24 hr post-stimulation, both IL-1b and TNF also significantly up-
regulated IFITM1 gene expression, and all three cytokines signif-
icantly increased IFITM3 mRNA levels. At 48 hr, IFITM1 mRNA
synthesis also was increased significantly by IL-6, and IFITM2
transcription was enhanced significantly at this time point by
both IL-6 and TNF (Figure 1E). Taken together, these data indi-
cate that IFITM1–3 gene expression is induced by secondary
signaling pathways, including those triggered by binding of IL-
1b, IL-6, and TNF to their cognate receptors, activated during
MTb infection in addition to being directly activated by MTb
and MyD88-dependent TLR ligation.
Knockdown of IFITM1–3 Expression Enhances
Intracellular Growth of MTb in Monocytes
To directly assess the role of IFITM proteins in MTb infection, we
stably transduced THP-1 cells with a lentiviral vector encoding
an shRNA targeting a conserved region present in IFITM1, 2,
and 3mRNAs. We infected these cells with mCherry-expressing
MTb (H37Rv-mCherry), after demonstrating that expression of
each IFITM was ablated by >80% (Figure 2A). As shown in a
representative flow cytometry assay in Figure 2B, after 24 hr,
control cells were 29.8% infected as compared to IFITM1–3
knockdown (KD) THP-1 cells, which were 51.8% infected. At
48 hr post-infection, control cells were 38.4% infected and
IFITM1–3 KD cells were 65% infected.
When we used colony-forming unit (CFU) assay to measure
bacterial growth, significant increases (p < 0.01) in MTb growth
were observed at 2 and 3 days post-infection in IFITM-KD versus
control THP-1 cells (Figure 2C), confirming the flow cytometry
data we obtained. Furthermore, bacterial uptake was similar in
both the IFITM-KD and control THP-1 cells (Figure 2C), indi-
cating that the IFITMs restrict MTb at a post-entry stage in hu-
man monocytes.
Overexpression of IFITM1, 2, or 3 Restricts MTb
Infection in Monocytes
To investigate the relative impact of each IFITM family member
on MTb growth in monocytes, we next overexpressed IFITM1,
IFITM2, or IFITM3 in THP-1 cells by lentiviral transduction (Fig-
ure S3). At 24 hr post-infection, H37Rv-mCherry signal was
lower in each IFITM-overexpressing cell line compared to cells
transduced with an empty lentiviral vector (Figure 3A). As shown
in Figure 3A, IFITM3 overexpression led to the greatest decrease
inMTb growth (38.5%compared to 26.7% for IFITM1 and 24.7%
for IFITM2).anMacrophages andMonocytic Cells in Response toMTb Infection
878 as indicated for 3, 24, and 48 hr and IFITM1–3 transcripts were measured.
r 3, 6, 24, and 48 hr and IFITM1–3 transcripts were measured.
Cys (100 ng/ml) or the TLR4 agonist LPS (100 ng/ml) for 3, 6, 24, and 48 hr and
ells expressing a control shRNA, were infected with MTb strain H37Rv or left
ng/ml), IL-6 (50 ng/ml), TNF (10 ng/ml), or IFN-b (100 ng/ml) for 24 and 48 hr.
the mean ± SEM from three independent experiments (*p% 0.05, **p% 0.01,
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Figure 2. Ablation of Endogenous IFITM1–3 Increases MTb Repli-
cation
(A) IFITM1, IFITM2, and IFITM3 mRNA levels were measured in THP-1 trans-
ducedwith a lentiviral vector encoding a single shRNA targeting IFITM1, 2, and
3, or a vector encoding a control shRNA.
(B) IFITM1–3 shRNA KD or control THP-1 cells were infected with MTb strain
H37Rv-mCherry for 24 or 48 hr and analyzed by flow cytometry. Gated area
CeTo quantitatively measure the impact of IFITM3 overexpres-
sion on H37Rv-mCherry infection, we utilized ImageStream
technology, which allowed us to capture images of individual
cells containing intracellular MTb. After eliminating cells from
the analysis that exhibited H37Rv-mCherry surface attachment
(Figures 3B and 3C; Figure S4), we used IDEAS software to mea-
sure mCherry pixel intensity in IFITM3-overexpressing and con-
trol cells. There was a significant decrease in mean per-cell
mCherry intensity in the IFITM3-overexpressing THP-1 cells
(p = 0.007) (Figure 3B). By contrast, there was a significant in-
crease inmean per-cell mCherry intensity in the IFITM-KD versus
control THP-1 cells (p < 0.0001) (Figure 3C), consistent with the
fluorescence-activated cell sorting (FACS) and CFU data, further
supporting a role for the IFITMs—and IFITM3 in particular—in re-
striction of MTb growth.
Intracellular Localization of IFITM3 Overlaps with MTb
Bacilli in Early and Late Phagosomes
IFITM3’s antiviral activity has been associated with its distribu-
tion to late endosomal/lysosomal membranes and its ability to
promote increases in the number and size of acidic intracellular
compartments (Feeley et al., 2011; Mudhasani et al., 2013; Wee
et al., 2012). To determine if a similar mechanismwas involved in
IFITM3’s modulation of MTb infection, we investigated the asso-
ciation of IFITM3 and MTb with endosomal compartments in
A549 human lung alveolar carcinoma cells. A549 cells transcribe
IFITM1–3 in response to IFN-b stimulation (Figure S5) and are a
long-standing model for MTb infection of the airway epithelium
(Bermudez and Goodman, 1996; McDonough and Kress,
1995), and they have been used extensively to examine IFITM
antiviral activity (Brass et al., 2009; Huang et al., 2011; John
et al., 2013). Furthermore, as we found in THP-1 cells, shRNA-
mediated depletion of the IFITMs in A549 cells led to greater
MTb growth at 24 (57%) and 48 (30%) hr post-infection (Fig-
ure S6), and overexpression of IFITM1, 2, or 3 in A549 cells in-
hibited MTb growth, with IFITM3 exhibiting the strongest effect
(Figures S6C and S6D), supporting the relevance of A549 cells
for examination of IFITM3-MTb intracellular association by
confocal microscopy.
Next, we introduced a C-terminal V5-tagged version of IFITM3
into A549 cells to investigate changes in intracellular IFITM3
distribution during MTb infection. Like endogenous IFITM3,
C-terminal epitope-tagged IFITM3 localizes mainly to late endo-
somes/lysosome in A549 cells (Amini-Bavil-Olyaee et al., 2013;
Feeley et al., 2011; Huang et al., 2011; Williams et al., 2014). After
infection of IFITM3-V5 or control A549 cells, H37Rv-mCherry
bacilli co-localized with IFITM3 at Rab5+ phagosomal compart-
ments (Figure 4A, top and graph; p < 0.01) and, to a relatively
greater degree, at late Rab7+ phagosomal compartments (Fig-
ure 4A, bottom and graph; p < 0.005), indicating that IFITM3 as-
sociates with MTb phagosomes that are likely progressing to
phagolysosomalmaturation.Wenote that IFITM3 overexpressionand numerical values show the percentage of the cells infected with bacilli. Dot
plots are representative of three independent experiments.
(C) CFU assay of IFITM-KD or control THP-1 cells at days 0, 2, and 3 post-
infection with H37Rv-mCherry. Results are the mean ± SEM from two exper-
iments (**p < 0.01).
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Figure 3. IFITM1, IFITM2, or IFITM3 Overexpression Inhibits MTb Replication in Monocytic Cells
(A) THP-1 cells transduced with an empty control vector or vectors encoding IFITM1, IFITM2, or IFITM3 were infected with MTb H37Rv-mCherry for
24 hr. Gated area and numerical values show the percentage of the cells infected with bacilli. Dot plots are representative of three independent
experiments.
(B and C) Representative images of intracellular mycobacteria that are associated with individual cells indicated after acquisition on an ImageStream X Mark II
instrument and IDEAS software analysis. Bright-field microscopy indicates cells magnified 603 and infected with MTb H37Rv-mCherry for 24 hr. THP-1 cells
were transduced with (B) control or IFITM3 overexpression vectors or (C) vectors encoding IFITM1–3 shRNA or control shRNA. Images shown from left to right are
as follows: bright field (gray) indicating cellular outline, MTb-mCherry fluorescence (red) indicating MTb, and merged image of MTb-mCherry fluorescence and
bright field showing intracellular MTb. Dot plot graphs on the right-hand side show the pixel intensity of intracellular mCherry in the infected cells. Results are from
one of two independent experiments, acquiring 2,500 cells per sample each time (**p < 0.01, ***p < 0.005).
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in the Presence of MTb Infection
(A) A549 cells transduced with IFITM3-V5 tag (IFITM3) or control vectors were infected with MTb H37Rv-mCherry as described in the Experimental Procedures.
(Top) MTb-mCherry- (red) infected cells were immunostained with anti-V5 (IFITM3, green), anti-Rab5 (white), and DAPI (nuclei, blue). The graph shows quan-
titativemeasurement ofMTb co-localizationwith IFITM3 and Rab5. (Bottom)MTb-mCherry- (red) infected cells were immunostained with anti-V5 (IFITM3, green),
anti-Rab7 (white), and DAPI (nuclei, blue). The graph shows quantitative measurement of MTb co-localization with IFITM3 and Rab7. Scale bar, 10 mM. Enlarged
images on the right-hand side of the merged images show the MTb-containing phagosomes. Data are representative of four independent experiments. Results
are the mean ± SEM (**p < 0.01, ***p < 0.005).
(B) THP-1 cells transduced with a control vector or a vector overexpressing IFITM3 were left uninfected (mock) or infected with MTb H37Rv for 48 hr, after which
they were incubated with LysoTracker Red for 2 hr. Histograms show LysoTracker Red signal in the control and IFITM3-overexpressing cells in the absence (left)
or presence (right) of MTb infection.increased the staining intensity of Rab7 (Figure 4, bottom),
consistent with previous observations (Feeley et al., 2011).
IFITM3 Overexpression Enhances Intracellular
Endosomal Acidification in MTb-Infected Cells
To determine whether IFITM3 overexpression can augment en-
dosomal acidity in the context of virulent MTb infection, we next
infected IFITM3-overexpressing or control THP-1 cells with
H37Rv-MTb and stained them with LysoTracker Red, a fluores-
cent indicator of acidic intracellular organelles. Levels of endo-
somal acidification were higher in IFITM3-overexpressingCeversus control THP-1 cells, and this was maintained and
even enhanced in the presence of MTb infection (Figure 4B).
These results indicate that endosomal acidification mediated
by MTb may be one mechanism underlying its antimycobacte-
rial activity.
DISCUSSION
Our findings expand the role of a well-established family of anti-
viral restriction factors to control of a major bacterial pathogen.
In a previous study, no difference was found in lung bacterialll Reports 13, 874–883, November 3, 2015 ª2015 The Authors 879
load between wild-type and Ifitm3/ C57BL/6 mice at 30 days
post-aerosol infection with H37Rv-MTb (Everitt et al., 2013).
However, only early time points (<30 days) post-infection were
evaluated in this study, and it is clear that many immunological
factors important for TB control become evident only at later
stages in mice (Mayer-Barber and Sher, 2015). We previously
demonstrated, for example, that MTb lung burden is equivalent
at 6 weeks post-infection in wild-type mice and mice deficient
in the transcription factor NFATp, but the NFATp/ mice suc-
cumbed more rapidly (median 119 versus 205 days) and lung
bacterial burden was 103 higher in these mice at the time of
death/sacrifice (Via et al., 2012). In another example, MTb lung
burden was higher in IL-6-deficient versus wild-type mice early
after infection, but the IL-6/ mice contained bacterial growth
at later time points (Saunders et al., 2000). Moreover, while three
IFITMs have been identified in humans, mice possess four Ifitm
genes (Sa¨llman Alme´n et al., 2012; Zhang et al., 2012), suggest-
ing that redundancy among the IFITMs may have precluded
clear identification of a phenotype. Finally, although the murine
TB model has proved valuable for the elucidation of immunoreg-
ulatory pathways involved in TB control that also are critical
in humans, inflammatory responses in mice, particularly at the
level of monocyte/macrophage function and TLR activation,
are imperfect representatives of what occurs in humans (Seok
et al., 2013), and the challenge strain used by Everitt et al.
(2013), H37Rv, is less virulent than clinical strains (Palanisamy
et al., 2009; Park et al., 2006). Thus, the study of TB in Ifitm3/
C57BL/6 mice (Everitt et al., 2013) does not rule out a role for
IFITM3, or the IFITM family, in the innate immune response to TB.
Intriguingly, a SNP in the IFITM3 promoter (rs3888188; T > G),
which reduces transcriptional activation of IFITM3, has been
associated with increased susceptibility to TB in Han Chinese
children (Shen et al., 2013). A C to T SNP in the IFITM3 cDNA,
which was speculated to disrupt a splice-acceptor site and pro-
duce an N-terminal truncated version of the protein, has been
associated with increased severity of influenza virus infection
and accelerated HIV disease (Everitt et al., 2012; Zhang et al.,
2013, 2015), although the impact of this SNP on influenza
morbidity/mortality in humans (Mills et al., 2014) and the impor-
tance of N-terminal truncation of IFITM3 on the restriction of
influenza virus infection (Williams et al., 2014) are still points of
debate. It is of interest to determine if these or other SNPs in
the genes encoding IFITM1–3 are associated with TB suscepti-
bility in other patient populations.
Our data demonstrate that MTb infection induces IFITM gene
expression. Previously, it was reported that LPS induces IFITM1
mRNA synthesis in human dendritic cells (Ishii et al., 2005); Ifitm1
and murine-specific Ifitm6 transcription in RAW264.7 macro-
phages (Han et al., 2011); and Ifitm3 gene expression in murine
astrocytes, a process that was dependent on autocrine IFNb
signaling (Nakajima et al., 2014). We found that MyD88 KD re-
duces MTb-induced IFITM1–3 mRNA levels, demonstrating a
direct role for TLRs and MyD88-dependent autocrine/paracrine
factors, such as IL-1b, in activation of these genes. Indeed, we
found that IL-1b also induces IFITM1–3 transcription in human
monocytes, extending previous findings that IL-1b activates
IFITM3mRNAsynthesis in hepatocarcinomacells andmurine as-
trocytes (Nakajima et al., 2014). As TNF and IL-6 also induced the880 Cell Reports 13, 874–883, November 3, 2015 ª2015 The Authorstranscription of IFITM1–3 in monocytes, it is likely that soluble
factors produced during MTb infection further amplify PRR-
driven IFITM1–3 mRNA levels. The cytosolic DNA sensor cyclic
GMP-AMP synthase (cGAS), which recently has been shown to
trigger type I IFN synthesis in MTb-infected cells (Collins et al.,
2015; Dey et al., 2015; Wassermann et al., 2015; Watson et al.,
2015), also may play a role in MTb-induced IFITM synthesis.
Arrest of phagosome maturation is a hallmark of virulent
MTb infection (Armstrong and Hart, 1971). A mechanism of
MTb-mediated phagosome arrest is the exclusion of the host
v-ATPase from the phagosomal membrane (Sturgill-Koszycki
et al., 1994; Wong et al., 2011). Notably, IFITM3 overexpression
leads to an increase in the size and number of acidic compart-
ments in murine and human cells (Feeley et al., 2011; Mudhasani
et al., 2013;Weeet al., 2012), and IFITM3 interactswith v-ATPase
and potentially stabilizes its association with endosomal mem-
branes (Wee et al., 2012). Our findings that IFITM3 co-localizes
with the MTb phagosome and that increased IFITM3-mediated
intracellular acidity is maintained even in the presence of MTb
infection suggest that IFITM3 (and potentially IFITM1/2) impedes
productive MTb infection in a manner similar to its antiviral
role. Because several other pathogenic intracellular bacteria,
including Salmonella enterica and Yersinia pestis, also depend
on phagosomal maturation arrest for survival and growth (Smith
and May, 2013), it is possible that the IFITMs may contribute to
host control of a diverse range of bacterial pathogens.
MTb appears to have emerged from Africa with the first hu-
mans (Gagneux, 2012). As gene duplication events have led to
diverse numbers of IFITM genes in the primate lineage (Zhang
et al., 2012), it is intriguing to speculate that the IFITM genes
have co-evolved with mycobacteria as well as viral pathogens
and have contributed to the constantly co-evolving host-path-
ogen dynamic driven by TB disease in humans.
EXPERIMENTAL PROCEDURES
Ethics Statement
For isolation of peripheral blood mononuclear cells (PBMCs), we obtained un-
identified, discarded leukocyte collars from the Boston Children’s Hospital
Blood Donor Center.
MTb Culture
The MTb strains H37Rv, H37Rv-mCherry (kindly provided by Dr. Sarah For-
tune; Sille´ et al., 2011), HN878, and CDC1551 were prepared as described
before (Ranjbar et al., 2009). Cultures were grown to an OD650 of 0.4 at 37
C
to ensure they were logarithmic growth phase, and bacteria were pelleted,
washed, resuspended in PBS, and passed through a 5-mM filter to ensure sin-
gle-cell suspension. Bacterial numbers were determined by measurement of
OD650. All the MTb infections were done at a ratio of 1:1 (cells:bacilli).
Cell Culture
PBMCs were isolated by Ficoll-Hypaque (Pharmacia) density gradient centri-
fugation. Monocytes were enriched by positive selection with CD14 microbe-
ads (STEMCELL Technologies) and then cultured at 1 3 106 cells per well in
six-well plates in RPMI-1640 medium with 2 mM L-glutamine (BioWhittaker),
supplemented with 5%heat-inactivated human AB serum (Atlanta Biologicals)
and 50 ng/ml recombinant human GM-CSF (R&D Systems). After 5 days, su-
pernatants were replaced with GM-CSF-free medium prior to experimental
analysis. More than 98% of the adherent cells obtained with this technique
were CD14+macrophages, as verified by flow cytometry. THP-1 cells were ob-
tained from ATCC and cultured in RPMI-1640 medium supplemented with
10% fetal calf serum (FCS, BioWhittaker). The 293T and A549 cells were
obtained from ATCC and were maintained in DMEM (BioWhittaker) supple-
mented with 10% FCS.
Cell Lines
Lentiviral plasmids (pLKO.1 parent vector) encoding an shRNA targeting hu-
man IFITM1–3, or a scrambled control shRNA sequence, were obtained
from Dharmacon and validated in our laboratory. The pLX304-IFITM3-V5 tag
plasmids, expressing IFITM3 protein and the pLX304-V5 parent vector, were
obtained from the Dana Farber/Harvard Cancer Center DNA Resource Core
and Addgene, respectively.
To generate IFITM1, IFITM2, and IFITM3 expression vectors, oligoDT-
primed cDNA was prepared from IFNb-stimulated THP-1 cells and used as
template for synthesis of IFITM1, IFITM2, or IFITM3 coding regions. A GGGGS
linker and flag tagwere incorporated in-frame at the 30 end of each IFITM cDNA
during PCR. The IFITM1-Flag, IFITM2-Flag, and IFITM3-Flag sequences were
cloned into MluI and NheI sites under the control of the human EF1a promoter
in a pLKO.1-derived vector that also encodes a human PGK-driven puromycin
resistance Pac gene.
Lentiviruses were generated by transfecting 293T cells with the plasmids
above in combination with the packaging plasmid psPAX2 and the envelope
plasmid pMD2.G using Effectene transfection reagent (QIAGEN). Superna-
tants were collected 24 and 48 hr post-transfection, clarified by centrifugation,
and stored at80C. THP-1 cells or A549 cells were transduced with lentiviral
particles in the presence of 8 mg/ml polybrene (Millipore) and spinoculation.
Transduced cells were selected and expanded by treatment with 1 mg/ml pu-
romycin or 10 mg/ml blasticidin. THP-1 cells stably transducedwith lentiviruses
encoding shRNAs against MyD88, IRAK1, or TRAF6 were described previ-
ously (Ranjbar et al., 2012).
qPCR
The mRNA expression levels were determined by SYBR Green-based real-
time PCR (Applied Biosystems) with the following gene-specific primers:
IFITM1 (forward, 50-ATCCTGTTACTGGTATTCGG-30; reverse, 50-TATAAACT
GCTGTATCTAGG-30 ); IFITM2 (forward, 50-GTTGGTCGTCCAGGCCCAGC-
30; reverse, 50-CTGTGGGGACAGGGCGAGGA-30); IFITM3 (forward, 50-GCTG
ATCTTCCAGGCCTATG-30; reverse, 50-GATACAGGACTCGGCTCCGG-3);
IL1B (forward, 50-GCTGAGGAAGATGCTGGTTC-30; reverse, 50-TCCATATCC
TGTCCCTGGAG-30); IL-6 (forward, 50-AGGAGACTTGCCTGGTGAAA-30;
reverse, 50-CAGGGGTGGTTATTGCATCT-30); IFNB1 (forward, 50-GAATGG
GAGGCTTGAATACTGCCT-30; reverse, 50-TAGCAAAGATGTTCTGGAGCATC
TC-30); TNF (forward, 50-TCTTCTCGAACCCCGAGTGA-30; reverse, 50-CCTCT
GATGGCACCACCA-30); and cyclophilin B (PPIB) (forward, 50-AGAAGAAG
GGGCCCAAAG-30; reverse, 50-AAAGATCACCCGGCCTACA-30).
The reaction conditions were 95C for 10 min followed by 40 cycles of 95C
for 15 s and 60C for 1min. The results were normalized to cyclophilin BmRNA
and expressed as relative values. Specificity of each primer set was validated
bymeasuring themRNA level of each IFITMmember in THP-1 cells individually
overexpressing IFITM1, 2, or 3 (Figure S3).
CFU Assay
THP-1 cells expressing the IFITMs’ shRNA or control shRNA (1 3 106) were
seeded in six-well plates in triplicate and infectedwith H37Rv. After a 3-hr incu-
bation at 37C, the cultures were treated with 50 mg/ml puromycin for 20 min.
Cells were washed three times with PBS; cultured in 3 ml fresh RPMI plus
10% FCS for 0, 48, and 72 hr; and incubated at 37C and 5% CO2. Following
each time point, cultures were terminated, cells were treated with lysis buffer
and sonicated, and serial dilutions were prepared and inoculated in Middle-
brook 7H11 agar in triplicate. Colonies were analyzed on day 25 post-infection.
Flow Cytometry
For standard cytometric analyses, cells were left uninfected or infected with
MTb-mCherry for the indicated time points, after which the cultures were
terminated. Cells were washed with PBS, fixed with 4% paraformaldehyde,
and analyzed with a five-laser FACSAria II machine (Becton Dickinson) accord-
ing to standard techniques. Results were analyzed using the FlowJo software
package.CeFor ImageStream-based analyses, IFITM3-overexpressing and control
THP-1 cells, or IFITM-KD or shRNA control THP-1 cells, were infected with
H37Rv-mCherry for 24 hr and then fixed with 4% paraformaldehyde. Next,
2,500 cells per sample were acquired using an Amnis ImageStreamX
Mark II machine (EMD Millipore), with simultaneous collection of bright field,
fluorescence, and scatter of images on a per-cell basis. Objective numerical
quantification of internalized H37Rv-mCherry was performed using IDEAS
software.
Fluorescence Microscopy
A549 cells stably transduced with the IFITM3-V5 tag construct or the empty
vector were seeded on a small coverslip in 12-well plates in fresh media and
were infectedwithMTb-mCherry for 3 hr, after which the cultureswere washed
and fresh media were added. Cells were further incubated at 37C for 20 hr.
MTb-infected cells were fixed with 4% paraformaldehyde before they were
blocked and permeabilized with buffer containing 5% normal donkey serum
and 0.3% Triton X-100 in PBS for 2 hr. Cells were labeled with 1:150 rabbit
anti-Rab5 or 1:100 rabbit anti-Rab7 antibody (Cell Signaling Technology) over-
night in antibody dilution buffer containing 1% BSA followed by 1:500 second-
ary donkey anti-rabbit DyLight 649 antibody (BioLegend) for 2 hr. Cells were
further labeled with mouse fluorescein isothiocyanate (FITC) anti-V5 antibody
(Invitrogen) overnight, after which slides were mounted in mounting media
containing DAPI. Images were captured with an Olympus (FV1000) confocal
microscope and Fluoview Software 2. Analysis was performed using ImageJ
software.
Staining of Acidified Compartments
THP-1 cells stably expressing IFITM3-V5 tag or empty vector were infected
with H37RvMTb for 48 hr, at which time they were incubated with LysoTracker
Red DND-99 (LTRed, Life Technologies) at 50 nM for 2 hr at 37C. Cells were
washed and fixed with 4% paraformaldehyde before analysis by flow cytom-
etry as described above.
Statistical Analysis
Where applicable, results are expressed as mean ± SEM. Comparison
between two groups was performed using the unpaired Student’s t test with
the aid of Microsoft Excel software. A p value % 0.05 was considered
significant.
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